Skip to main content
. 2019 Jan 16;20(2):373. doi: 10.3390/ijms20020373

Figure 2.

Figure 2

Overview of ncAA with reported use for SDSL. p-Acetyl-l-phenylalanine 1, p-azido-l-phenylalanine 2, Nε-propargyloxycarbonyl-l-lysine 3, Nε-Cyclooct-2-ynyloxycarbonyl-l-lysine 4, Nε-Bicyclo[6.1.0]non-2-yn-9-ylmethoxycarbonyl-l-lysine 5, Nε-1-oxy-2,2,5,5- tetramethylpyrroline-3-ylmethoxycarbonyl-l-lysine 6.